352 related articles for article (PubMed ID: 10487628)
1. Trends in cancer of the cervix uteri in Sweden following cytological screening.
Bergström R; Sparén P; Adami HO
Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
[TBL] [Abstract][Full Text] [Related]
2. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
[TBL] [Abstract][Full Text] [Related]
3. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.
Smith HO; Tiffany MF; Qualls CR; Key CR
Gynecol Oncol; 2000 Aug; 78(2):97-105. PubMed ID: 10926787
[TBL] [Abstract][Full Text] [Related]
4. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
Nieminen P; Kallio M; Hakama M
Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
[TBL] [Abstract][Full Text] [Related]
5. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.
Bray F; Loos AH; McCarron P; Weiderpass E; Arbyn M; Møller H; Hakama M; Parkin DM
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):677-86. PubMed ID: 15767349
[TBL] [Abstract][Full Text] [Related]
6. Effect of screening on the incidence of cervical cancer in Alberta.
Starreveld AA; Hill GB; Brown LB; Koch M
Can Med Assoc J; 1981 Nov; 125(10):1105-9. PubMed ID: 7326641
[TBL] [Abstract][Full Text] [Related]
7. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
8. The changing pattern of cervical cancer in Northern Ireland 1965-1989.
Robertson JH; Woodend B
Ulster Med J; 1992 Apr; 61(1):19-23. PubMed ID: 1621297
[TBL] [Abstract][Full Text] [Related]
9. Incidence trends of adenocarcinoma of the cervix in 13 European countries.
Bray F; Carstensen B; Møller H; Zappa M; Zakelj MP; Lawrence G; Hakama M; Weiderpass E
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2191-9. PubMed ID: 16172231
[TBL] [Abstract][Full Text] [Related]
10. Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival.
Sherman ME; Wang SS; Carreon J; Devesa SS
Cancer; 2005 Mar; 103(6):1258-64. PubMed ID: 15693030
[TBL] [Abstract][Full Text] [Related]
11. Cancer of the uterine cervix in Norway by histologic type, 1970-84.
Eide TJ
J Natl Cancer Inst; 1987 Aug; 79(2):199-205. PubMed ID: 3474452
[TBL] [Abstract][Full Text] [Related]
12. Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985-2000.
Visioli CB; Zappa M; Ciatto S; Iossa A; Crocetti E
Cancer Detect Prev; 2004; 28(6):461-4. PubMed ID: 15582270
[TBL] [Abstract][Full Text] [Related]
13. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
[TBL] [Abstract][Full Text] [Related]
14. [Results of the Leiden mass screening for cervix uteri carcinoma; the 'young' (24-34 years) versus the 'old' (35-54 years) group of women].
Boon ME; de Graaff Guilloud-Gentenaar JC; Beck S
Ned Tijdschr Geneeskd; 1990 Aug; 134(32):1545-9. PubMed ID: 2392176
[TBL] [Abstract][Full Text] [Related]
15. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
Sigurdsson K
Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer in New Zealand: national and regional trends.
Cox B; Borman B
N Z Med J; 1994 Aug; 107(984):323-6. PubMed ID: 8072727
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
Smrkolj S; Rakar S; Mozina A; Erzen M
Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of cancer of the cervix: global and national perspective.
Shanta V; Krishnamurthi S; Gajalakshmi CK; Swaminathan R; Ravichandran K
J Indian Med Assoc; 2000 Feb; 98(2):49-52. PubMed ID: 11016150
[TBL] [Abstract][Full Text] [Related]
19. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
[TBL] [Abstract][Full Text] [Related]
20. Cytological screening history of patients with early invasive cervical cancer.
Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
